E97A62A3-E4D3-435C-9165-C0075358578E
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 4.566360052562418
- age_years
- 63
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | 812834CD-DA8F-4C0C-A49E-31D4A882D0E0 | — | — | 0.954 |
| 2 | 54B7F258-FE9A-4EFE-87FB-465D587B1170 | — | — | 0.950 |
| 3 | 6D1D9992-DA2B-419A-A80A-9EBCDA831754 | — | — | 0.947 |
| 4 | 6410821A-1C6A-4F64-939F-196313B8F1E5 | — | — | 0.943 |
| 5 | C14BEAAE-A766-4ADE-A9B4-674D8717591F | — | — | 0.941 |
| 6 | BB96C5BA-CA50-40B4-B22A-3FCFE46AB11C | — | — | 0.939 |
| 7 | 2E040577-EA0C-4876-9F43-A180DA38F733 | — | — | 0.933 |
| 8 | 821FCEC2-41D4-48D9-8B75-D87405D075F7 | — | — | 0.929 |
| 9 | AB5294B5-4A59-493A-9016-C2778735745F | — | — | 0.929 |
| 10 | 6B8CAF74-45C6-4C20-8126-A99F73346198 | — | — | 0.928 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 41 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.596 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.580 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.548 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.504 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.504 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.502 | Remibrutinib | — uncovered |
| DNA_REPAIR | 0.488 | Idelalisib | — uncovered |
| MTORC1_SIGNALING | 0.435 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.420 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.379 | Idelalisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.379 | Idelalisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.376 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.371 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.347 | Remibrutinib | — uncovered |
| APOPTOSIS | 0.342 | Idelalisib | — uncovered |
| PEROXISOME | 0.342 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.334 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.324 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.321 | Inavolisib | — uncovered |
| P53_PATHWAY | 0.299 | Idelalisib | — uncovered |